Zhang, J., Zhai, L., Sun, J.D., Yang, C.C., Zhang, Y., Sun, Y.N., Wu, Z.J. and Luo, H.J. (2026) Effect of Glycine Betaine on ...
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...
BioVersys Announces First Patient First Visit in HABP/VABP Pivotal Phase 3 RIV-TARGET Trial of BV100
BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP) caused by carbapenem-resistant ...
MedPage Today on MSN
'Incredible' Response Rates in Atopic Dermatitis With Drugs From China
Historically good results with IL-4 inhibitors raise questions with U.S. audience ...
Daraxonrasib delivered a median overall survival of 13.2 months versus 6.7 months with standard chemotherapy in previously ...
C-Suite executives are being warned that a previously undocumented Microsoft attack platform, codename Venom, can neutralize ...
Ethics committees and funding agencies often receive protocols that involve either too many or too few animals to answer the specific research question being investigated. It is evident that a greater ...
A preview of Crystalmancers from PAX East and a look at what's next for the Tetris-like Roguelike.
St. Louis officials on Wednesday said the city’s Community Development Administration is putting $544,887 behind the Good ...
Morning Overview on MSN
New procedure shows sharp gains for combat-related PTSD
Several experimental treatments for combat-related post-traumatic stress disorder are producing striking short-term symptom ...
Morning Overview on MSN
Study links GLP-1 drugs to GI side effects and possible infection benefits
GLP-1 receptor agonists, the class of drugs that includes semaglutide and similar medications now widely prescribed for ...
Spironolactone showed no significant benefit in reducing the composite of cardiovascular mortality and heart failure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results